Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 2Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Pain 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Etoposide 6Radiotherapy 4Cisplatin 3Docetaxel 2Carboplatin 2venetoclax 1trametinib 1toripalimab 1tislelizumab 1talazoparib 1sacituzumab govitecan 1rovalpituzumab tesirine 1regorafenib 1poly ICLC 1pembrolizumab 1olaparib 1obatoclax 1nintedanib 1fludarabine phosphate 1etoposide phosphate 1enoxaparin sodium 1durvalumab 1alpha-Tocopherol 1Vitamin E 1Topotecan 1Tomography, Optical Coherence 1Thymalfasin 1Taxes 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Small Cell Lung Carcinoma × Genistein × Clear all
NCT00769990 2017-12-13

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

Masonic Cancer Center, University of Minnesota

Phase 1/2 Withdrawn
BreastDermatologicGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pain, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡